January 27, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Chris Edwards
| Re: | Alector, Inc. |
Registration Statement on FormS-1
(FileNo. 333-236094)
Acceleration Request
Requested Date: Wednesday, January 29, 2020
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Alector, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on FormS-l (FileNo. 333-236094) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael E. Coke at (650)565-3596 or Melissa S. Rick at (650) 849-3059.
[Signature page follows]
| Sincerely, |
| ALECTOR, INC. |
| /s/ Arnon Rosenthal |
| Arnon Rosenthal, Ph.D. |
| Chief Executive Officer |
| Enclosures | ||
| cc (w/o enclosures): | Stephanie Yonker, Ph.D., Alector, Inc.
Kenneth A. Clark, Wilson Sonsini Goodrich & Rosati, P.C. | |
| Michael E. Coke, Wilson Sonsini Goodrich & Rosati, P.C. | ||
| Melissa S. Rick, Wilson Sonsini Goodrich & Rosati, P.C. | ||
| Alan F. Denenberg, Davis Polk & Wardwell LLP | ||
| Stephen Salmon, Davis Polk & Wardwell LLP | ||
